多巴胺与谷氨酸神经传递交互作用在精神分裂症中的相关性
综述指出,仅针对多巴胺或谷氨酸系统的模型无法完全复现精神分裂症病理生理全貌,仅限单一系统的治疗策略也不能有效治疗阳性、阴性和认知三大症状域。越来越多证据表明两系统间广泛交互,破坏纹状体和前脑的DA-谷氨酸环路可能汇聚于精神分裂症病理生理;作者提出共释放DA和谷氨酸的神经元亚群是两系统整合的新节点。
要点
- 仅多巴胺或多巴胺单独模型均不能复现精神分裂症全谱病理生理。
- 仅针对单一系统的治疗不能有效治疗阳性、阴性及认知三大症状域。
- 共释放DA和谷氨酸的神经元亚群可能为两系统整合提供新连接点。
核心结论
- 越来越多的证据提示DA与谷氨酸系统间存在广泛交互,更有效的治疗可能需要同时靶向DA和谷氨酸信号。
- 破坏纹状体和前脑的DA-谷氨酸环路可能汇聚于精神分裂症病理生理,但其机制及贡献仍不清楚。
- 作者提出涉及共释放DA和谷氨酸的神经元亚群的功能改变为两系统整合提供新节点,可能是理解精神分裂症病理生理的关键缺失环节。
- 更好地理解这些神经元DA/谷氨酸共释放机制可能为精神分裂症病理生理提供新见解并导向更有效的治疗。
研究设计与样本
- 综述,检索范围及方法原文未报告。
主要发现
- 多数研究关注仅释放DA或仅释放谷氨酸的神经元,但两类模型单独均不能复现精神分裂症病理生理全谱。
- 仅限DA或谷氨酸单一系统的治疗策略不能有效治疗精神分裂症阳性、阴性及认知三大症状域。
- 除仅释放DA或谷氨酸神经元在环路或系统水平的交互外,共释放DA和谷氨酸的神经元亚群功能改变可能提供两系统整合的新节点。
临床怎么用
- 原文未报告具体的临床实践推荐或阈值。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dopamine (DA) and glutamate neurotransmission are strongly implicated in schizophrenia pathophysiology. While most studies focus on contributions of neurons that release only DA or glutamate, neither DA nor glutamate models alone recapitulate the full spectrum of schizophrenia pathophysiology. Similarly, therapeutic strategies limited to either system cannot effectively treat all three major symptom domains of schizophrenia: positive, negative, and cognitive symptoms. Increasing evidence suggests extensive interactions between the DA and glutamate systems and more effective treatments may therefore require the targeting of both DA and glutamate signaling. This offers the possibility that disrupting DA-glutamate circuitry between these two systems, particularly in the striatum and forebrain, culminate in schizophrenia pathophysiology. Yet, the mechanisms behind these interactions and their contributions to schizophrenia remain unclear. In addition to circuit- or system-level interactions between neurons that solely release either DA or glutamate, here we posit that functional alterations involving a subpopulation of neurons that co-release both DA and glutamate provide a novel point of integration between DA and glutamate systems, offering a key missing link in our understanding of schizophrenia pathophysiology. Better understanding of mechanisms underlying DA/glutamate co-release from these neurons may therefore shed new light on schizophrenia pathophysiology and lead to more effective therapeutics.
引用
- Buck SA, Quincy Erickson-Oberg M, Logan RW, et al. Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia. Mol Psychiatry. 2022. PMID: 35681081. doi:10.1038/s41380-022-01649-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。